[go: up one dir, main page]

SG11201808775PA - Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna - Google Patents

Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna

Info

Publication number
SG11201808775PA
SG11201808775PA SG11201808775PA SG11201808775PA SG11201808775PA SG 11201808775P A SG11201808775P A SG 11201808775PA SG 11201808775P A SG11201808775P A SG 11201808775PA SG 11201808775P A SG11201808775P A SG 11201808775PA SG 11201808775P A SG11201808775P A SG 11201808775PA
Authority
SG
Singapore
Prior art keywords
international
sequencing
california
pct
stanford
Prior art date
Application number
SG11201808775PA
Inventor
Stephen R Quake
Chunxiao Song
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of SG11201808775PA publication Critical patent/SG11201808775PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/191—Modifications characterised by incorporating an adaptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101—Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/185—Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/04—Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property —, Organization 111111110111101110101011111010111110111010111111101101111101111101111011111 International Bureau ... ..... ..Yi j ..... ..... (10) International Publication Number (43) International Publication Date WO 2017/176630 Al 12 October 2017(12.10.2017) WIPO I PCT (51) International Patent Classification: Office of the General Counsel, Building 170, 3rd Floor, C12N 15/00 (2006.01) C12Q 1/68 (2006.01) Main Quad, P.O. Box 20386, Stanford, California 94305- C12N 15/07 (2006.01) G01N 33/50 (2006.01) 2038 (US). (21) International Application Number: (72) Inventor; and PCT/US2017/025735 (71) Applicant (for US only): QUAKE, Stephen R. [US/US]; 318 Campus Drive, Stanford, California 94305 (US). (22) International Filing Date: 3 April 2017 (03.04.2017) (72) Inventor: SONG, Chunxiao; Ludwig Institute, University of Oxford, Old Road Campus Research Building, Heading- (25) Filing Language: English ton, Oxford OX3 7DQ (GB). (26) Publication Language: English (74) Agent: KEDDIE, James S.; 201 Redwood Shores Park- (30) Priority Data: way, Suite 200, Redwood City, California 94065 (US). 62/319,702 7 April 2016 (07.04.2016) US (81) Designated States (unless otherwise indicated, for every 62/444,122 9 January 2017 (09.01.2017) US kind of national protection available): AE, AG, AL, AM, 62/461,712 21 February 2017 (21.02.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (71) Applicant: THE BOARD OF TRUSTEES OF THE LE- BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, LAND STANFORD JUNIOR UNIVERSITY [US/US]; DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, [Continued on next page] = (54) Title: NONINVASIVE DIAGNOSTICS BY SEQUENCING 5-HYDROXYMETHYLATED CELL-FREE DNA (57) : Provided herein is a method of sequencing hydroxy- - _ ciDNA methyated cell-free DNA. In some embodiments, the method com- tag to hydroxymethyated DNA _ prises adding an affinity only mo- - a 5h mc 9 _.2____ lecules in a sample of cfDNA, enriching for the DNA molecules that are tagged with the affinity tag; and sequencing the enriched end repair &A-tailing DNA molecules. adapter ligation -,__ illurnina \" — adapter , -/' • 9 J , — ¨ , , , selective labeling of 5hmC with biotin , \----e-------, / • El biotin • \ . \ • _ • • — / I capture 5hmC + extensive wash M 1-1 strepdavidin beads • q • PCR from beads ir 0 final libary M IN FIG, 1 A ,—, IN ,—, © ei O WO 2017/176630 Al MUNRO 111111111111111111111111113111111111111111 Ell 0111110 111110111111111111 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. — of inventorship (Rule 4.17(iv)) (84) Designated States (unless otherwise indicated, for every Published: kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, — with international search report (Art. 21(3)) with sequence listing part of description (Rule 5.2(a)) TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE,
SG11201808775PA 2016-04-07 2017-04-03 Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna SG11201808775PA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662319702P 2016-04-07 2016-04-07
US201762444122P 2017-01-09 2017-01-09
US201762461712P 2017-02-21 2017-02-21
PCT/US2017/025735 WO2017176630A1 (en) 2016-04-07 2017-04-03 Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna

Publications (1)

Publication Number Publication Date
SG11201808775PA true SG11201808775PA (en) 2018-11-29

Family

ID=60000634

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808775PA SG11201808775PA (en) 2016-04-07 2017-04-03 Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna

Country Status (14)

Country Link
US (7) US10718010B2 (en)
EP (2) EP3440205B1 (en)
JP (2) JP7143221B2 (en)
CN (1) CN109312399B (en)
AU (1) AU2017246318B2 (en)
CA (1) CA3019836A1 (en)
DK (1) DK3440205T3 (en)
ES (1) ES2882329T3 (en)
MX (1) MX391039B (en)
PL (1) PL3440205T3 (en)
PT (1) PT3440205T (en)
RU (1) RU2742355C2 (en)
SG (1) SG11201808775PA (en)
WO (1) WO2017176630A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9115386B2 (en) 2008-09-26 2015-08-25 Children's Medical Center Corporation Selective oxidation of 5-methylcytosine by TET-family proteins
US10023909B2 (en) 2011-12-13 2018-07-17 Oslo Universitetssykehus Hf Methods and kits for detection of methylation status
ES2786984T3 (en) 2012-11-30 2020-10-14 Cambridge Epigenetix Ltd Oxidizing agent for modified nucleotides
KR20160011670A (en) 2013-05-28 2016-02-01 라모트 앳 텔-아비브 유니버시티 리미티드 Detection of hydroxymethylcytosine bases
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
EP3274440A4 (en) 2015-03-27 2019-03-06 Exact Sciences Corporation DETECTION OF SOPHAGE DISORDERS
EP3355939A4 (en) 2015-09-30 2019-04-17 Trustees of Boston University MICROBIAL CIRCUIT BREAKERS OF DEADMAN AND PASSCODE TYPE
CN111526793A (en) 2017-10-27 2020-08-11 朱诺诊断学公司 Apparatus, system and method for ultra low volume liquid biopsy
JP7136899B2 (en) 2018-01-08 2022-09-13 ルドウイグ インスティテュート フォー キャンサー リサーチ エルティーディー Cytosine-modified, bisulfite-free, base resolution specific
JP7206284B2 (en) 2018-02-14 2023-01-17 ブルースター ジェノミクス， インコーポレイテッド Method for epigenetic analysis of DNA, especially cell-free DNA
EP3762513A1 (en) * 2018-03-08 2021-01-13 St. Johns University Circulating serum cell-free dna biomarkers and methods
DE202019005627U1 (en) 2018-04-02 2021-05-31 Grail, Inc. Methylation markers and targeted methylation probe panels
CN112534067A (en) * 2018-06-22 2021-03-19 蓝星基因组股份有限公司 Hydroxymethylation analysis of cell-free nucleic acid samples for partitioning tissue of origin and related methods of use
WO2020061380A1 (en) 2018-09-19 2020-03-26 Bluestar Genomics, Inc. Cell-free dna hydroxymethylation profiles in the evaluation of pancreatic lesions
CA3111887A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
CN113166796A (en) 2018-10-04 2021-07-23 蓝星基因组股份有限公司 Simultaneous sequencing-based analysis of proteins, ribosomes, and cell-free nucleic acids from a single biological sample
JP7645178B2 (en) * 2018-10-19 2025-03-13 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー Composition for treating gastric cancer containing SYT11 inhibitor as an active ingredient
CN109321647A (en) * 2018-10-26 2019-02-12 苏州森苗生物科技有限公司 The construction method of marking composition and methylolation nucleic acid library
WO2020194057A1 (en) * 2019-03-22 2020-10-01 Cambridge Epigenetix Limited Biomarkers for disease detection
KR20220004645A (en) * 2019-03-27 2022-01-11 주노 다이어그노스틱스, 인크. Optimized Ultra-Low Volume Liquid Biopsy Methods, Systems and Devices
WO2020263978A1 (en) * 2019-06-25 2020-12-30 Accuragen Holdings Limited Methods and systems for disease detection
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
EP4127223A1 (en) * 2020-03-30 2023-02-08 Vilnius University Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of genomic sites
CA3187549A1 (en) 2020-07-30 2022-02-03 Cambridge Epigenetix Limited Compositions and methods for nucleic acid analysis
KR20230049122A (en) 2020-08-19 2023-04-12 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 Detection of non-Hodgkin's lymphoma
AU2022213409A1 (en) 2021-01-29 2023-08-17 Exact Sciences Corporation Detecting the presence or absence of multiple types of cancer
CA3226127A1 (en) * 2021-07-20 2023-01-26 Freenome Holdings, Inc. Compositions and methods for improved 5-hydroxymethylated cytosine resolution in nucleic acid sequencing
CN113528616A (en) * 2021-07-26 2021-10-22 深圳泰莱生物科技有限公司 A detection method for capturing cfDNA 5hmC fragments
CN115851934A (en) * 2021-09-17 2023-03-28 北京大学 Single gene detection method and application thereof
CN115992203B (en) * 2022-07-26 2024-07-26 生工生物工程（上海）股份有限公司 Method for constructing genome-wide hydroxymethylation capture sequencing library
CN115491414A (en) * 2022-09-21 2022-12-20 安徽中医药大学第一附属医院(安徽省中医院) A comprehensive analysis method for the differential expression of m6A methylation modifications in the whole transcriptome of rheumatoid arthritis
WO2024159053A1 (en) 2023-01-25 2024-08-02 Guardant Health, Inc. Nucleic acid methylation profiling method
US20240344141A1 (en) 2023-03-22 2024-10-17 Clearnote Health, Inc. Cell-free dna analysis in the detection and monitoring of pancreatic cancer using a combination of features

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712126A (en) 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
US6287825B1 (en) 1998-09-18 2001-09-11 Molecular Staging Inc. Methods for reducing the complexity of DNA sequences
US20050233340A1 (en) 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for assessing CpG methylation
US20100273151A1 (en) * 2004-05-28 2010-10-28 Fred Hutchinson Cancer Research Center Genome-wide analysis of palindrome formation and dna methylation
EP1899486A4 (en) * 2005-06-08 2009-07-22 Millennium Pharm Inc Methods for the identification, assessment, and treatment of patients with cancer therapy
WO2007087312A2 (en) 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Molecular counting
EP2164985A4 (en) 2007-06-01 2014-05-14 454 Life Sciences Corp System and meth0d for identification of individual samples from a multiplex mixture
EP2191011B1 (en) 2007-08-29 2017-03-29 Illumina Cambridge Limited Method for sequencing a polynucleotide template
US9115386B2 (en) 2008-09-26 2015-08-25 Children's Medical Center Corporation Selective oxidation of 5-methylcytosine by TET-family proteins
WO2010048337A2 (en) * 2008-10-22 2010-04-29 Illumina, Inc. Preservation of information related to genomic dna methylation
US20100323348A1 (en) 2009-01-31 2010-12-23 The Regents Of The University Of Colorado, A Body Corporate Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process
AU2010232972B2 (en) * 2009-04-01 2016-10-27 Dxterity Diagnostics Incorporated Chemical ligation dependent probe amplification (CLPA)
WO2011025819A1 (en) * 2009-08-25 2011-03-03 New England Biolabs, Inc. Detection and quantification of hydroxymethylated nucleotides in a polynucleotide preparation
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
DE112011100297B4 (en) * 2010-01-20 2017-08-24 New England Biolabs, Inc. Compositions, methods and related applications for cleaving modified DNA
WO2011127136A1 (en) 2010-04-06 2011-10-13 University Of Chicago Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc)
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
ES2523140T3 (en) 2010-09-21 2014-11-21 Population Genetics Technologies Ltd. Increased confidence in allele identifications with molecular count
US20120122087A1 (en) 2010-11-17 2012-05-17 Weiwei Li 5-Hydroxymethylcytosine as a biomarker for early detection, treatment and prognostic monitoring of cancer
US9611510B2 (en) 2011-04-06 2017-04-04 The University Of Chicago Composition and methods related to modification of 5-methylcytosine (5-mC)
EP3907297A1 (en) 2011-04-15 2021-11-10 The Johns Hopkins University Safe sequencing system
ES2665071T3 (en) 2012-02-17 2018-04-24 Fred Hutchinson Cancer Research Center Compositions and methods to identify mutations accurately
US9752188B2 (en) 2012-03-20 2017-09-05 University Of Washington Through Its Center For Commercialization Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
US9732390B2 (en) * 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
EP3351661B1 (en) * 2012-11-26 2025-05-21 The University of Toledo Methods for standardized sequencing of nucleic acids and uses thereof
HK1216655A1 (en) * 2013-03-13 2016-11-25 Sequenom, Inc. Primers for dna methylation analysis
WO2015021282A1 (en) * 2013-08-09 2015-02-12 New England Biolabs, Inc. Detecting, sequencing and/or mapping 5-hydroxymethylcytosine and 5-formylcytosine at single-base resolution
US9932623B2 (en) * 2013-08-19 2018-04-03 Abbott Molecular Inc. Nucleotide analogs
CN106103743A (en) * 2014-01-07 2016-11-09 Imppc私人基金会 Methods for generating double-stranded DNA libraries and sequencing methods for identifying methylated cytosines
EP3099822A4 (en) * 2014-01-30 2017-08-30 The Regents of the University of California Methylation haplotyping for non-invasive diagnosis (monod)
GB201405226D0 (en) * 2014-03-24 2014-05-07 Cambridge Entpr Ltd Nucleic acid preparation method
CN106661631B (en) * 2014-06-06 2021-04-02 康奈尔大学 Methods for specifically targeted capture of regions of the human genome and transcriptome from blood
EP2975116B1 (en) * 2014-07-16 2019-08-21 Max-Delbrück-Centrum für Molekulare Medizin Tgif2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof
WO2016153434A1 (en) * 2015-03-24 2016-09-29 Agency For Science, Technology And Research (A*Star) Normalization methods for measuring gene copy number and expression
US11162139B2 (en) 2016-03-02 2021-11-02 Shanghai Epican Genetech Co. Ltd. Method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine

Also Published As

Publication number Publication date
ES2882329T3 (en) 2021-12-01
AU2017246318A1 (en) 2018-11-08
US20200283838A1 (en) 2020-09-10
CN109312399A (en) 2019-02-05
EP3440205B1 (en) 2021-05-26
PT3440205T (en) 2021-08-06
RU2018138848A (en) 2020-05-12
JP7143221B2 (en) 2022-09-28
AU2017246318A2 (en) 2018-11-08
RU2018138848A3 (en) 2020-12-15
WO2017176630A1 (en) 2017-10-12
CN109312399B (en) 2023-02-03
AU2017246318B2 (en) 2023-07-27
US20190017109A1 (en) 2019-01-17
JP2019520791A (en) 2019-07-25
MX391039B (en) 2025-03-21
US10718010B2 (en) 2020-07-21
US20200248249A1 (en) 2020-08-06
US20200277667A1 (en) 2020-09-03
US20200299760A1 (en) 2020-09-24
EP3440205A4 (en) 2019-04-03
US20200248248A1 (en) 2020-08-06
RU2742355C2 (en) 2021-02-05
US20200277666A1 (en) 2020-09-03
EP3440205A1 (en) 2019-02-13
EP3929290A1 (en) 2021-12-29
MX2018012156A (en) 2019-02-07
PL3440205T3 (en) 2021-11-22
DK3440205T3 (en) 2021-08-16
JP2022120007A (en) 2022-08-17
CA3019836A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
SG11201808775PA (en) Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna
SG11201803703UA (en) Anti-complement factor c1q fab fragments and uses thereof
SG11201804807VA (en) Computer architecture and method for modifying data intake parameters based on a predictive model
SG11201807025SA (en) Crispr/cas systems for c-1 fixing bacteria
SG11201909881TA (en) Complex comprising odh unit with integrated oxygen separation module
SG11201807444PA (en) Transposase-mediated imaging of the accessible genome
SG11201805562QA (en) Genomic infrastructure for on-site or cloud-based dna and rna processing and analysis
SG11201909154SA (en) Bispecific antibodies specifically binding to pd1 and lag3
SG11201906161VA (en) Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201805449PA (en) Methods of making chimeric antigen receptor -expressing cells
SG11201806284TA (en) Low pressure separator having an internal divider and uses therefor
SG11201408362SA (en) Production of long chain polyunsaturated fatty acids in plant cells
SG11201808476SA (en) Recycling of polymer matrix composite
SG11201809530PA (en) Method for recovery of phosphate
SG11201408536WA (en) METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF
SG11201805709RA (en) Anti-pro/latent myostatin antibodies and methods of use thereof
SG11201806496SA (en) Antigen binding proteins that bind pd-l1
SG11201809374VA (en) Cd40l-fc fusion polypeptides and methods of use thereof
SG11201909419XA (en) Hydrogel for cell culture and biomedical applications
SG11201909708VA (en) Methods and antibodies for diabetes-related applications
SG11201907129VA (en) Motion generating platform assembly
SG11201903557SA (en) Methods for screening b cell lymphocytes
SG11201903193WA (en) Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate
SG11201900609PA (en) Method and system for providing buffer solutions